150 related articles for article (PubMed ID: 11757749)
1. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.
Homma S; Toda G; Gong J; Kufe D; Ohno T
J Gastroenterol; 2001 Nov; 36(11):764-71. PubMed ID: 11757749
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice.
Zhang H; Zheng SS; Jiang GP; Wu LH; Zhu F; Yang ZL
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):235-40. PubMed ID: 15138117
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunotherapy for hepatocellular carcinoma.
Onji M; Akbar F; Horiike N
J Gastroenterol; 2001 Nov; 36(11):794-7. PubMed ID: 11757756
[No Abstract] [Full Text] [Related]
4. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
[TBL] [Abstract][Full Text] [Related]
6. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
7. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
Yin XY; Wang L; Lu MD; Li BJ; Huang JF
Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
[TBL] [Abstract][Full Text] [Related]
8. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
9. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice.
Irie M; Homma S; Komita H; Zeniya M; Kufe D; Ohno T; Toda G
Int J Cancer; 2004 Aug; 111(2):238-45. PubMed ID: 15197777
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of immunizations with fusions of dendritic and hepatocellular carcinoma cells in mice].
Zhang H; Zheng SS; Jiang GP; Zhou L; Xie HY
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):648-51. PubMed ID: 15623369
[TBL] [Abstract][Full Text] [Related]
13. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas].
Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612
[TBL] [Abstract][Full Text] [Related]
14. Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.
Huang Y; Mao Q; He J; Su J; Peng Y; Liang W; Hu Z; Zhou S; Lu X; Zhao Y
Sci Rep; 2017 Apr; 7():46544. PubMed ID: 28436481
[TBL] [Abstract][Full Text] [Related]
15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
16. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
[TBL] [Abstract][Full Text] [Related]
17. Immature dendritic cell/tumor cell fusions induce potent antitumour immunity.
Takeda A; Homma S; Okamoto T; Kufe D; Ohno T
Eur J Clin Invest; 2003 Oct; 33(10):897-904. PubMed ID: 14511362
[TBL] [Abstract][Full Text] [Related]
18.
Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C
Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
Su H; Li B; Zheng L; Wang H; Zhang L
Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
